DCM
PCRX icon

Dupont Capital Management’s Pacira BioSciences PCRX Stock Holding History

Dupont Capital Management’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-25,664
Closed -$1.16M – 1356
2019
Q4 		$1.16M Hold
25,664
– – 0.03% 528
2019
Q3 		$977K Buy
+25,664
New +$1.02M 0.02% 532
2017
Q4 		– Sell
-15,090
Closed -$567K – 981
2017
Q3 		$567K Buy
15,090
+1,821
+14% +$73.3K 0.01% 647
2017
Q2 		$633K Sell
13,269
-5,192
-28% -$241K 0.01% 628
2017
Q1 		$842K Sell
18,461
-5,087
-22% -$220K 0.02% 558
2016
Q4 		$761K Buy
23,548
+17,791
+309% +$594K 0.02% 553
2016
Q3 		$197K Hold
5,757
– – ﹤0.01% 641
2016
Q2 		$194K Hold
5,757
– – ﹤0.01% 648
2016
Q1 		$305K Sell
5,757
-7,232
-56% -$423K 0.01% 593
2015
Q4 		$997K Buy
+12,989
New +$735K 0.02% 472

Other funds holding PCRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
SCM
Spyglass Capital Management San Francisco, California $1.41B AUM 7.96% 1-Year Est. Return